In 2016, a randomized trial from NYU found that a single dose of psilocybin delivered rapid improvements in anxiety and depression in cancer patients when combined with psychotherapy. A follow-up study found that 71–100% of participants reported that the improvement in depression and anxiety had lasted five years—with participants “rating it among the most personally meaningful experiences of their lives.”
One thought on “Wellness Evidence Study: Single Dose of Psilocybin Reduced Depression and Anxiety for 5 Years”
Interesting study and promising.
I hope it will work exactly as described. Just how long the development phase will be, I guess, is unknown.